Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Pharmacodynamics of Human Insulin Injection
NCT07608692Phase 1Completed
- Sponsor
- The United Laboratories International Holdings
- Start
- Aug 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of human insulin in diabetes mellitus (DM) (2 arms), sponsored by The United Laboratories International Holdings. Primary endpoints: Peak Plasma Concentration, Area under the plasma concentration-time curve from time 0 to time τ and 2 more. Started Aug 2025; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07608692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07608692.